Table 6.
Bioactive Principle | Nanovector | Type of Delivery Systems | Experimental Model | Reference |
---|---|---|---|---|
Squalene |
Nanocapsules | Polyelectrolyte multilayer NC | In vitro | [151] |
Lycopene |
Nanoemulsions | Aqueous propolis and lycopene | In vivo (albino guinea pigs) | [157] |
Nanoparticles | SLN | In vitro | [158,159] | |
Cyclodextrins | Inclusion in CD | In vitro | [160] | |
p-Cymene |
Cyclodextrins | Inclusion in CD | In vitro | [162,163] |
(−)-Linalool |
Cyclodextrins | Inclusion in CD | In vivo (rodents) | [164,166] |
Carvacrol |
Cyclodextrins | Inclusion in CD | In vivo (rodents with induced tumors) | [167] |